ArticleFrontiers in oncology2022

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.

Matthias A Fante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.